Immune megakaryocytes, PD1 deletions in CTCL, and COVID-19 vaccine and VITT

episode

Blood Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

5 year plans don't work. Here's how to build a routine that actually helps you achieve your goals with Dr Rangan Chatterjee 23 min · 21 Sep 2026 · Working Hard with Grace Beverley

Being trans in Britain in 2026 29 min · 21 Sep 2026 · Today in Focus

The Mormon Founding of Salt Lake City 51 min · 21 Sep 2026 · American History Hit

I Sent Robbie Williams A Drunk 5AM Message The Night I Lost My Uncle | Window Kid 1h 2m · 21 Sep 2026 · On The Mend

Chris Fagan's 4th consecutive AFL Grand Final | The Wisdom & Experience of Robert Craddock (21.09.26) 7 min · 21 Sep 2026 · Whateley

Bite: Should more companies give employees shares? 3 min · 21 Sep 2026 · Shared Lunch

Report any issue

Source

Recorded07 Oct 2021

Publisherfeeds.transistor.fm ↗

Handlerec:11742119

Show notes

In this week’s episode, we’ll review a study providing new insights on megakaryocyte diversity and function, including a unique subpopulation that may act as immune cells. Next, we’ll review research that intriguingly reveals a putative role for the PD1 gene in cutaneous T-cell lymphoma. Lastly, we’ll conclude with a report demonstrating a lack of cross-reaction between the antibodies that cause vaccine-induced thrombocytopenia and thrombosis, and the COVID-19 spike protein.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in